Cardlytics, Inc. (CDLX) Revenue History
Annual and quarterly revenue from 2015 to present
CDLX Revenue Over Time (2015–2025)
CDLX Revenue Growth History
7 of 10 years with positive growth- FY2015 revenue growth
- N/A
- FY2016 revenue growth
- +45.3%
- FY2017 revenue growth
- +15.6%
- FY2018 revenue growth
- +15.6%
- FY2019 revenue growth
- +39.6%
- FY2020 revenue growth
- -11.2%
- FY2021 revenue growth
- +42.9%
- FY2022 revenue growth
- +11.8%
- FY2023 revenue growth
- +3.6%
- FY2024 revenue growth
- -10.0%
- FY2025 revenue growth
- -16.2%
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32.9M | -36.8% |
| Q2 2026 | $36.9M | -41.7% |
| Q1 2026 | $34.3M | -44.6% |
| Q4 2025 | $56.1M | -24.2% |
| Q3 2025 | $52.0M | -22.4% |
| Q2 2025 | $63.2M | -9.2% |
| Q1 2025 | $61.9M | -8.4% |
| Q4 2024 | $74.0M | -17.0% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
CDLX's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
CDLX Revenue Analysis (2015–2025)
Current Revenue & Growth
As of November 8, 2026, Cardlytics, Inc. (CDLX) generated trailing twelve-month (TTM) revenue of $160.2 million, reflecting significant decline in growth of -36.8% year-over-year. The most recent quarter (Q3 2026) recorded $32.9 million in revenue, down 10.8% sequentially.
Historical Growth Trajectory
CDLX's 5-year compound annual growth rate (CAGR) stands at +4.5%, indicating moderate growth over time. The 3-year CAGR of -7.9% is below the 5-year average, signalling a growth deceleration in recent years. Cardlytics, Inc.'s highest annual revenue of $309.2 million was recorded in 2023.
Revenue by Segment
CDLX's revenue is primarily driven by Cost per Redemption (51%), Cost per Served Sales (31%), and Bridg Subscription Revenue (8%). With over half of revenue concentrated in Cost per Redemption, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Communication Services sector peers — including PERI (+2.9% YoY), MGNI (+9.1% YoY), and APPS (+19.2% YoY) — CDLX has underperformed the peer group in revenue growth. Compare CDLX vs PERI →
CDLX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CDLXCurrent | $160M | -36.8% | +4.5% | -20.2% | |
 PERI | $440M | +2.9% | +6.0% | -3.1% | |
 MGNI | $714M | +9.1% | +26.4% | 13.7% | |
 APPS | $565M | +19.2% | -5.4% | 6.0% | |
 ACMR | $901M | +29.1% | +41.9% | 12.1% | |
 TTD | $2.9B | +11.6% | +28.2% | 20.3% |
CDLX Historical Revenue Data (2015–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $233.3M | -16.2% | $105.1M | 45.0% | $-47,141,000 | -20.2% |
| 2024 | $278.3M | -10.0% | $120.9M | 43.4% | $-195,499,000 | -70.2% |
| 2023 | $309.2M | +3.6% | $130.4M | 42.2% | $-135,670,000 | -43.9% |
| 2022 | $298.5M | +11.8% | $112.6M | 37.7% | $-457,778,000 | -153.3% |
| 2021 | $267.1M | +42.9% | $103.3M | 38.7% | $-122,599,000 | -45.9% |
| 2020 | $186.9M | -11.2% | $63.3M | 33.9% | $-53,923,000 | -28.9% |
| 2019 | $210.4M | +39.6% | $79.5M | 37.8% | $-17,325,000 | -8.2% |
| 2018 | $150.7M | +15.6% | $54.7M | 36.3% | $-40,917,000 | -27.2% |
| 2017 | $130.4M | +15.6% | $50.1M | 38.4% | $-17,099,000 | -13.1% |
| 2016 | $112.8M | +45.3% | $40.4M | 35.8% | $-56,232,000 | -49.8% |
| 2015 | $77.6M | - | $25.1M | 32.4% | $-39,639,000 | -51.1% |
CDLX Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
11+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CDLX — Frequently Asked Questions
Quick answers to the most common questions about buying CDLX stock.
Is CDLX's revenue growth accelerating or slowing?
CDLX revenue is declining -36.8% year-over-year. TTM revenue fell to $160M, contrasting with the 5-year CAGR of +4.5%. The reversal reflects either macro headwinds or company-specific challenges.
What is CDLX's revenue history from 2015 to 2026?
Cardlytics, Inc. (CDLX) revenue history spans 2015 to 2026. TTM revenue as of 2026 is $160M, growing at -36.8% YoY. The 5-year CAGR is +4.5%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is CDLX's long-term revenue growth rate (CAGR)?
Cardlytics, Inc.'s 5-year revenue CAGR of +4.5% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -36.8% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for CDLX.
Why does CDLX's quarterly revenue fluctuate?
CDLX quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Cardlytics, Inc.'s revenue data from 2015 to 2026 shows full historical quarterly detail on this page.
How is CDLX's revenue distributed by segment?
CDLX reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does CDLX's revenue compare to industry peers?
Cardlytics, Inc. (CDLX) with TTM revenue of $160M and -36.8% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.